1. Novel platform for the preparation of synthetic orally active peptidomimetics with hemoregulating activity. II. Hemosuppressor activity of 2,5-diketopiperazine-based cyclopeptides
- Author
-
Alexandra Goryacheva, Anastasia A. Ignatova, Oleg N. Yatskin, Vadim T. Ivanov, Vladislav Deigin, Olga Ksenofontova, and Alexey V. Feofanov
- Subjects
0301 basic medicine ,Peptidomimetic ,Stereochemistry ,Guinea Pigs ,Immunology ,Peptide ,Diketopiperazines ,Peptides, Cyclic ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Animals ,Humans ,Immunology and Allergy ,Immunosuppression Therapy ,Pharmacology ,chemistry.chemical_classification ,Biological Products ,Thymocytes ,Dipeptide ,Stereoisomerism ,Biological activity ,Dipeptides ,2,5-Diketopiperazine ,Hematopoiesis ,Amino acid ,Mice, Inbred C57BL ,030104 developmental biology ,Orally active ,chemistry ,030220 oncology & carcinogenesis ,Mice, Inbred CBA ,Female ,Peptidomimetics ,Enantiomer ,Peptides - Abstract
The novel chemical platform formed by the branched piperazine-2,5-dione peptide derivatives (2,5-diketopiperazines) for creating non-invasive biologically active peptidomimetics has been developed. A successful application of this approach to orally available hemostimulatory peptidomimetics was demonstrated for all-L cyclopeptide from the Glu-Trp-peptide family. In the 1980s, we have separated and characterized a number of dipeptides from the thymus homogenate. The most active peptide Glu-Trp has been studied and developed into the immunostimulating drug Thymogen. The inversion of the amino acid optical form endows the dipeptides with suppressor properties: D-Glu-D-Trp-OH and D-Glu-(D-Trp)-OH, inhibit proliferation of hemopoietic progenitors in the intact bone marrow. Based on the peptide D-Glu-(D-Trp)-OH, the new immunosuppressive drug Thymodepressin has been prepared. In this work, we applied the platform mentioned above to the design and synthesis of orally active hemosuppressive Thymodepressin® analogs. The novel data for the hemosuppressor activity of the dipeptide D-Glu(D-Trp-OH)-OH and its cyclopeptide analogs are discussed. A new example is presented of a rare phenomenon when enantiomeric molecules demonstrate reciprocal (i.e., opposite) biological activities.
- Published
- 2020
- Full Text
- View/download PDF